These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases]. Lafay JP; Poupon R; Legendre C; Homberg JC; Darnis F Gastroenterol Clin Biol; 1983 May; 7(5):523-8. PubMed ID: 6873565 [No Abstract] [Full Text] [Related]
16. [Tienilic acid as a likely cause of "auto immune" active hepatitis (author's transl)]. Eugène C; Patriarche C; Bergue A; Quevauvilliers J Nouv Presse Med; 1980 Jun; 9(27):1885-7. PubMed ID: 6157146 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new uricosuric diuretic--ticrynafen. Kosman ME JAMA; 1979 Dec; 242(26):2876-8. PubMed ID: 513260 [TBL] [Abstract][Full Text] [Related]
18. Acute reversible renal impairment produced by a uricosuric diuretic. Hubbell FA; Weber MA; Megaffin BB; Brewer DD West J Med; 1980 Nov; 133(5):444-6. PubMed ID: 7467301 [No Abstract] [Full Text] [Related]
19. [For instance Selacryn]. Bauch W Med Welt; 1980 Feb; 31(7):III. PubMed ID: 7366404 [No Abstract] [Full Text] [Related]
20. The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics. Johnson MW; Mitch WE Drugs; 1981 Mar; 21(3):220-5. PubMed ID: 7261949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]